![FACS analysis of human buffy coat cells using GTX00493 CD8 antibody [LT8]. FACS analysis of human buffy coat cells using GTX00493 CD8 antibody [LT8].](https://www.genetex.com/upload/website/prouct_img/normal/GTX00493/GTX00493_20191025_AP_006_30_w_23053121_131.webp)
FACS analysis of human buffy coat cells using GTX00493 CD8 antibody [LT8].
CD8 antibody [LT8]
GTX00493
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman, Monkey, Mouse, Primate
TargetCD8A
Overview
- SupplierGeneTex
- Product NameCD8 antibody [LT8]
- Delivery Days Customer9
- ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDLT8
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID925
- Target nameCD8A
- Target descriptionCD8 subunit alpha
- Target synonymsCD8, CD8alpha, IMD116, Leu2, p32, T-cell surface glycoprotein CD8 alpha chain, CD8 antigen, alpha polypeptide (p32), CD8a molecule, Leu2 T-lymphocyte antigen, OKT8 T-cell antigen, T cell co-receptor, T-cell antigen Leu2, T-lymphocyte differentiation antigen T8/Leu-2, T8 T-cell antigen
- HostMouse
- IsotypeIgG1
- Protein IDP01732
- Protein NameT-cell surface glycoprotein CD8 alpha chain
- ReactivityHuman, Monkey, Mouse, Primate
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Ma Q, Chen Y, Qin Q, et al. CXCL13 expression in mouse 4T1 breast cancer microenvironment elicits antitumor immune response by regulating immune cell infiltration. Precis Clin Med. 2021,4(3):155-167. doi: 10.1093/pcmedi/pbab020Read this paper
- Chebloune Y, Moussa M, Arrode-Brusés G, et al. A single lentivector DNA based immunization contains a late heterologous SIVmac251 mucosal challenge infection. Vaccine. 2020,38(21):3729-3739. doi: 10.1016/j.vaccine.2020.03.053Read this paper
- Huang CP, Chen CC, Shyr CR. The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer. Cytotherapy. 2017,19(10):1233-1245. doi: 10.1016/j.jcyt.2017.06.010Read this paper
- Büchner SM, Sliva K, Bonig H, et al. Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells. Clin Exp Immunol. 2013,173(2):355-64. doi: 10.1111/cei.12121Read this paper
- Lask A, Goichberg P, Cohen A, et al. TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement. J Immunol. 2011,187(4):2006-14. doi: 10.4049/jimmunol.1100095Read this paper






